HUGHES SYNDROME & QUALITY OF LIFE

We have had our empirical paper on Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQOL) using the SF-36  accepted for publication in LUPUS (SAGE Publications). The journal’s impact factor is: 2.481. It is ranked 15th out of 30 Rheumatology journals. The paper can be cited as:

Georgopoulou, S., Efraimidou, S., MacLennan, SJ., Ibrahim, F and Cox, T. (in press) Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQOL) using the SF-36. LUPUS.

My particular thanks go to Sofia Georgopoulou for crafting this paper through and to all my other colleagues at Kings College and Aberdeen University who were involved.
______________________________________________________________